Brief: Magenta Therapeutics Inc Received Notice From Nasdaq That Co Is Not Been In Compliance With Minimum Bid Price Requirement
02/02/2023 22:16
Feb 2 (Reuters) - Magenta Therapeutics Inc MGTA.O :
* MAGENTA THERAPEUTICS INC - ON JANUARY 31, RECEIVED NOTICE
FROM
NASDAQ THAT CO IS NOT BEEN IN COMPLIANCE WITH MINIMUM BID PRICE
REQUIREMENT
Further company coverage: MGTA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Dianthus Therapeutics
See all newsU.S. RESEARCH ROUNDUP- Adobe, Chewy, Mosaic
Brief: Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
U.S. RESEARCH ROUNDUP- Berkshire Hathaway, Exxon Mobil, Honeywell Technologies
Dianthus Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Dianthus Therapeutics Q2 net loss widens as R&D costs rise